Update on the june 6 and 7 2012 who treatment optimization diagnostics workstream meeting
This presentation is the property of its rightful owner.
Sponsored Links
1 / 13

Update on the June 6 and 7, 2012 WHO Treatment Optimization Diagnostics Workstream meeting PowerPoint PPT Presentation


  • 40 Views
  • Uploaded on
  • Presentation posted in: General

Update on the June 6 and 7, 2012 WHO Treatment Optimization Diagnostics Workstream meeting. Joseph Perriëns World Health Organization Geneva. LABORATORY MONITORING OF ART IN ADULTS WHO 2010 "GUIDING PRINCIPLES".

Download Presentation

Update on the June 6 and 7, 2012 WHO Treatment Optimization Diagnostics Workstream meeting

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Update on the june 6 and 7 2012 who treatment optimization diagnostics workstream meeting

Update on the June 6 and 7, 2012 WHO Treatment Optimization Diagnostics Workstreammeeting

Joseph Perriëns

World Health Organization

Geneva


Laboratory monitoring of art in adults who 2010 guiding principles

LABORATORY MONITORING OF ART IN ADULTS WHO 2010 "GUIDING PRINCIPLES"

These recommendations are being re-assessed as part of the development of WHO's 2013 consolidated guidelines on ART

Laboratory monitoring is not a prerequisite for the initiation of ART.

CD4 and viral load testing are not essential for monitoring patients on ART.

Symptom-directed laboratory monitoring for safety and toxicity is recommended for those on ART.

If resources permit, use viral load in a targeted approach to confirm suspected treatment failure based on immunological and/or clinical criteria.

If resources permit, use viral load in a routine approach, measured every 6 months, with the objective of detecting failure earlier than would be the case if immunological and/or clinical criteria were used to define failure.

International AIDS Conference 2012


Diagnosis of hiv infection and monitoring art in infants and young children who 2010

DIAGNOSIS OF HIV INFECTION AND MONITORING ART IN INFANTS AND YOUNG CHILDREN – WHO 2010

These recommendations are being re-assessed as part of the development of WHO's 2013 consolidated guidelines on ART

It is strongly recommended that all HIV-exposed infants have HIV virological testing at 4 – 6 weeks of age or at the earliest opportunity thereafter.

The following assays (and respective specimen types) are strongly recommended for use: HIV DNA on whole blood specimen or DBS, HIV RNA on plasma or DBS, Up24 Ag on plasma or DBS. "Exercise caution in interpreting negative results when using HIV RNA or Up24 if infant is established on ART."

In infants with an initial positive virological test result, it is strongly recommended that …/…a second specimen be collected to confirm the initial positive virological test result.

HIV VL measurement in monitoring treatment: "As required or symptom directed"

International AIDS Conference 2012


Objectives of the meeting

Objectives of the meeting

To articulate consensus on technologies which need to be deployed nowin HIV programs

To identify which technologies need to be developed in short, medium and longer term

International AIDS Conference 2012


Technology deployment levels

Technology deployment levels

InternationalAIDS Conference 2012


Update on the june 6 and 7 2012 who treatment optimization diagnostics workstream meeting

International AIDS Conference 2012


Update on the june 6 and 7 2012 who treatment optimization diagnostics workstream meeting

International AIDS Conference 2012


Update on the june 6 and 7 2012 who treatment optimization diagnostics workstream meeting

International AIDS Conference 2012


Viral load and early diagnosis in infants eid

Viral load and Early diagnosis in infants (EID)

  • Short term needs

  • POC EID and VL testsfor use in health centre/office and first referral lab settings

  • Medium/longer term needs

  • Instrument free POC test for use in community

  • Combo tests (CD4/VL)

    • Semi-automated devices for deployment at level 2 and up.

International AIDS Conference 2012


Hiv drug resistance

HIV Drug Resistance

7/19/2012 Mention of any product or manufacturer in this presentation should not be interpreted as their endorsement by WHO

International AIDS Conference 2012


Update on the june 6 and 7 2012 who treatment optimization diagnostics workstream meeting

International AIDS Conference 2012


Update on the june 6 and 7 2012 who treatment optimization diagnostics workstream meeting

  • Medium and longer term needs

  • Combo tests (CD4/VL)

  • Home sample collection tools

International AIDS Conference 2012


Acknowledgements

Acknowledgements

International AIDS Conference 2012


  • Login